1. Home
  2. MFM vs ASMB Comparison

MFM vs ASMB Comparison

Compare MFM & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFM
  • ASMB
  • Stock Information
  • Founded
  • MFM 1986
  • ASMB 2005
  • Country
  • MFM United States
  • ASMB United States
  • Employees
  • MFM N/A
  • ASMB N/A
  • Industry
  • MFM Finance Companies
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MFM Finance
  • ASMB Health Care
  • Exchange
  • MFM Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • MFM 223.2M
  • ASMB 225.9M
  • IPO Year
  • MFM N/A
  • ASMB 2010
  • Fundamental
  • Price
  • MFM $5.40
  • ASMB $37.09
  • Analyst Decision
  • MFM
  • ASMB Strong Buy
  • Analyst Count
  • MFM 0
  • ASMB 5
  • Target Price
  • MFM N/A
  • ASMB $44.25
  • AVG Volume (30 Days)
  • MFM 108.1K
  • ASMB 122.6K
  • Earning Date
  • MFM 01-01-0001
  • ASMB 11-10-2025
  • Dividend Yield
  • MFM 4.08%
  • ASMB N/A
  • EPS Growth
  • MFM N/A
  • ASMB N/A
  • EPS
  • MFM 0.03
  • ASMB N/A
  • Revenue
  • MFM N/A
  • ASMB $37,191,000.00
  • Revenue This Year
  • MFM N/A
  • ASMB $14.29
  • Revenue Next Year
  • MFM N/A
  • ASMB N/A
  • P/E Ratio
  • MFM $176.67
  • ASMB N/A
  • Revenue Growth
  • MFM N/A
  • ASMB 31.30
  • 52 Week Low
  • MFM $4.37
  • ASMB $7.75
  • 52 Week High
  • MFM $5.48
  • ASMB $37.71
  • Technical
  • Relative Strength Index (RSI)
  • MFM 53.55
  • ASMB 76.27
  • Support Level
  • MFM $5.35
  • ASMB $31.02
  • Resistance Level
  • MFM $5.45
  • ASMB $36.23
  • Average True Range (ATR)
  • MFM 0.05
  • ASMB 1.83
  • MACD
  • MFM -0.00
  • ASMB 0.40
  • Stochastic Oscillator
  • MFM 59.09
  • ASMB 87.04

About MFM MFS Municipal Income Trust

MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: